Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Elevated chemokine CC-motif receptor-like 2 (CCRL2) promotes cell migration and invasion in glioblastoma.

Yin F, Xu Z, Wang Z, Yao H, Shen Z, Yu F, Tang Y, Fu D, Lin S, Lu G, Kung HF, Poon WS, Huang Y, Lin MC.

Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):168-72. doi: 10.1016/j.bbrc.2012.10.120. Epub 2012 Nov 6.

PMID:
23142225
2.

The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells.

Wang LP, Cao J, Zhang J, Wang BY, Hu XC, Shao ZM, Wang ZH, Ou ZL.

Med Oncol. 2015 Nov;32(11):254. doi: 10.1007/s12032-015-0696-6. Epub 2015 Oct 20.

PMID:
26487662
3.

Up-regulated expression and activation of the orphan chemokine receptor, CCRL2, in rheumatoid arthritis.

Galligan CL, Matsuyama W, Matsukawa A, Mizuta H, Hodge DR, Howard OM, Yoshimura T.

Arthritis Rheum. 2004 Jun;50(6):1806-14.

4.

Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells.

Monnier J, Lewén S, O'Hara E, Huang K, Tu H, Butcher EC, Zabel BA.

J Immunol. 2012 Jul 15;189(2):956-67. doi: 10.4049/jimmunol.1102871. Epub 2012 Jun 13.

5.

Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.

Yoshimura T, Oppenheim JJ.

Exp Cell Res. 2011 Mar 10;317(5):674-84. doi: 10.1016/j.yexcr.2010.10.023. Epub 2010 Nov 4. Review.

6.

Role of aquaporin-4 in the regulation of migration and invasion of human glioma cells.

Ding T, Ma Y, Li W, Liu X, Ying G, Fu L, Gu F.

Int J Oncol. 2011 Jun;38(6):1521-31. doi: 10.3892/ijo.2011.983. Epub 2011 Mar 21.

PMID:
21424125
7.

Increased migration of a human glioma cell line after in vitro CyberKnife irradiation.

Canazza A, Calatozzolo C, Fumagalli L, Bergantin A, Ghielmetti F, Fariselli L, Croci D, Salmaggi A, Ciusani E.

Cancer Biol Ther. 2011 Oct 1;12(7):629-33. Epub 2011 Oct 1.

PMID:
21775821
8.

LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.

Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, Cao L, Shen S, Li G.

J Cell Biochem. 2008 Jan 1;103(1):245-55.

PMID:
17549698
9.

EFA6A enhances glioma cell invasion through ADP ribosylation factor 6/extracellular signal-regulated kinase signaling.

Li M, Ng SS, Wang J, Lai L, Leung SY, Franco M, Peng Y, He ML, Kung HF, Lin MC.

Cancer Res. 2006 Feb 1;66(3):1583-90.

10.

Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.

Farsam V, Basu A, Gatzka M, Treiber N, Schneider LA, Mulaw MA, Lucas T, Kochanek S, Dummer R, Levesque MP, Wlaschek M, Scharffetter-Kochanek K.

Oncotarget. 2016 Dec 13;7(50):83554-83569. doi: 10.18632/oncotarget.13446.

11.

The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells.

Nakada M, Niska JA, Miyamori H, McDonough WS, Wu J, Sato H, Berens ME.

Cancer Res. 2004 May 1;64(9):3179-85.

12.

IL-1β microenvironment promotes proliferation, migration, and invasion of human glioma cells.

Fathima Hurmath K, Ramaswamy P, Nandakumar DN.

Cell Biol Int. 2014 Dec;38(12):1415-22. doi: 10.1002/cbin.10353. Epub 2014 Jul 31.

PMID:
25053165
13.

17AEP-GA, an HSP90 antagonist, is a potent inhibitor of glioblastoma cell proliferation, survival, migration and invasion.

Miekus K, Kijowski J, Sekuła M, Majka M.

Oncol Rep. 2012 Nov;28(5):1903-9. doi: 10.3892/or.2012.1996. Epub 2012 Aug 27.

PMID:
22941268
14.

Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines.

Koo S, Martin GS, Schulz KJ, Ronck M, Toussaint LG.

BMC Cancer. 2012 Apr 10;12:143. doi: 10.1186/1471-2407-12-143.

15.

Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.

Gessler F, Voss V, Dützmann S, Seifert V, Gerlach R, Kögel D.

Neuroscience. 2010 Feb 17;165(4):1312-22. doi: 10.1016/j.neuroscience.2009.11.049. Epub 2009 Dec 1.

PMID:
19958818
16.

Inhibition of collagen XVI expression reduces glioma cell invasiveness.

Bauer R, Ratzinger S, Wales L, Bosserhoff A, Senner V, Grifka J, Grässel S.

Cell Physiol Biochem. 2011;27(3-4):217-26. doi: 10.1159/000327947. Epub 2011 Apr 1.

17.

Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness.

Lemke D, Pfenning PN, Sahm F, Klein AC, Kempf T, Warnken U, Schnölzer M, Tudoran R, Weller M, Platten M, Wick W.

Clin Cancer Res. 2012 Jan 1;18(1):105-17. doi: 10.1158/1078-0432.CCR-11-0880. Epub 2011 Nov 11.

18.

Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells.

Delamarre E, Taboubi S, Mathieu S, Bérenguer C, Rigot V, Lissitzky JC, Figarella-Branger D, Ouafik L, Luis J.

Am J Pathol. 2009 Aug;175(2):844-55. doi: 10.2353/ajpath.2009.080920. Epub 2009 Jul 2.

19.

Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma.

Xu BJ, An QA, Srinivasa Gowda S, Yan W, Pierce LA, Abel TW, Rush SZ, Cooper MK, Ye F, Shyr Y, Weaver KD, Thompson RC.

Int J Oncol. 2012 Jun;40(6):1995-2003. doi: 10.3892/ijo.2012.1355. Epub 2012 Feb 3.

PMID:
22307528
20.

EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion.

Nakada M, Niska JA, Tran NL, McDonough WS, Berens ME.

Am J Pathol. 2005 Aug;167(2):565-76.

Supplemental Content

Support Center